BP’s St Jude Medical STJ Stock Holding History

BP’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-35,000	Closed	-$2.81M	–	458
2016 Q4	$2.81M	Sell	35,000 -46,000	-57%	-$3.65M	0.11%	243
2016 Q3	$6.46M	Buy	81,000 +29,000	+56%	+$2.34M	0.25%	117
2016 Q2	$4.06M	Buy	52,000 +22,000	+73%	+$1.57M	0.16%	172
2016 Q1	$1.65M	Hold	30,000	–	–	0.07%	277
2015 Q4	$1.85M	Sell	30,000 -40,000	-57%	-$2.52M	0.08%	262
2015 Q3	$4.42M	Buy	70,000 +36,000	+106%	+$2.57M	0.2%	146
2015 Q2	$2.48M	Hold	34,000	–	–	0.09%	237
2015 Q1	$2.22M	Hold	34,000	–	–	0.07%	263
2014 Q4	$2.21M	Hold	34,000	–	–	0.06%	267
2014 Q3	$2.04M	Hold	34,000	–	–	0.06%	257
2014 Q2	$2.35M	Hold	34,000	–	–	0.07%	225
2014 Q1	$2.22M	Buy	+34,000	New	+$2.21M	0.07%	231

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

BP's STJ Position: Q1 2017 in Review

BP sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 35,000 shares — an estimated $2.81M sold.

BP first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $6.46M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

BP reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
BP sold 35,000 St Jude Medical shares in Q1 2017, an estimated $2.81M.
BP first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
BP's St Jude Medical position peaked at $6.46M in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on BP's 13F filing for Q1 2017, filed 9 May 2017.